No Data
Why the Market Dipped But Ginkgo Bioworks Holdings, Inc. (DNA) Gained Today
BofA Securities Initiates Ginkgo Bioworks(DNA.US) With Sell Rating, Announces Target Price $0.25
Express News | Ginkgo Bioworks Holdings Inc : BofA Global Research Cuts Price Objective to $0.25 From $0.8
Express News | Syngenta Partners With Ginkgo Bioworks To Boost The Launch Of Biologicals
Express News | Syngenta Collaborates With Ginkgo Bioworks to Enable Faster Launch of Innovative Biologicals
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?
Rigid Bull : I voted for it. but founders have super voting shares![rolling_on_the_floor_laughing 🤣](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f923.png)